Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells
Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or...
Gespeichert in:
Veröffentlicht in: | Experimental hematology 2007-05, Vol.35 (5), p.782-792 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 792 |
---|---|
container_issue | 5 |
container_start_page | 782 |
container_title | Experimental hematology |
container_volume | 35 |
creator | Rozenveld-Geugien, Marjan Baas, Inge O van Gosliga, Djoke Vellenga, Edo Schuringa, Jan Jacob |
description | Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or by using the Rac inhibitor NSC23766. In long-term MS5 cocultures (leukemic) expansion, migration, adhesion, and presence of stem/progenitor cells were monitored in both normal as well as leukemic CD34+ cells. Results Inhibition of Rac signaling impaired migration and adhesion of cord blood (CB) CD34+ cells on MS5 stroma. Long-term inhibition of Rac during a 5-week coculture period on stroma prevented association of hematopoietic progenitors with the bone marrow stromal cells and resulted in a dramatic decrease in the primitive stem cell frequency (long-term culture-initiating cell) in a dose-dependent manner. Many of these phenotypes were reversed in the presence of activated Rac1-V12, including improved migration toward, and association with, MS5 cells. CD34+ AML cells were characterized by elevated levels of Rac activity (five of seven patients) and enhanced migration and adhesion to MS5 bone marrow stroma as compared to CB CD34+ cells. A dramatic decrease was observed in the formation of leukemic cobblestone area–forming cells as well as strongly diminished clonal expansion in the presence of the Rac inhibitor NSC23766. Conclusion Our data indicate that Rac signal transduction is required for the maintenance and expansion of both normal as well as leukemic stem/progenitor cells by mediating their interaction with stromal cells. |
doi_str_mv | 10.1016/j.exphem.2007.02.006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70620388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301472X07001117</els_id><sourcerecordid>70620388</sourcerecordid><originalsourceid>FETCH-LOGICAL-c461t-e59b7362f0b2cbe23087a6abdba063db97e0f96a9bd874701dc3e2ec1139762a3</originalsourceid><addsrcrecordid>eNqFkUuLFDEQx4Mo7rj6DURy8ta9lWSm07kIsqwPWBB8gLeQTlc7me1OepP0unvyq5t2BgQvngLh_6j6FSEvGdQMWHNxqPF-3uNUcwBZA68Bmkdkw1opKi6Uekw2IIBVW8m_n5FnKR0AYLdT8JScMbmTUnG5Ib-u7mfjkwuehoH6ECczUuN7OuJyg5OzdL9MxtNSZHKYg8Nc_lLG6WKO4Qd6l0OkFscx0Yi3i4uY6Gdjqwl7ZzL21PmM0di8Vvx0eV_MMawtf0zPyZPBjAlfnN5z8u3d1dfLD9X1p_cfL99eV3bbsFzhTnVSNHyAjtsOuYBWmsZ0fWegEX2nJMKgGqO6vpVbCay3AjlaxoSSDTfinLw-5papbxdMWU8urRMYj2FJWkLDQbRtEW6PQhtDShEHPUc3mfigGegVvD7oI3i9gtfAdQFfbK9O-UtXVv9rOpEugjdHAZYt7xxGnaxDbwumiDbrPrj_NfwbYEfnnTXjDT5gOoQl-kJQM52KQX9Zj7_eHiQAY0yK3wnIrtk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70620388</pqid></control><display><type>article</type><title>Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Rozenveld-Geugien, Marjan ; Baas, Inge O ; van Gosliga, Djoke ; Vellenga, Edo ; Schuringa, Jan Jacob</creator><creatorcontrib>Rozenveld-Geugien, Marjan ; Baas, Inge O ; van Gosliga, Djoke ; Vellenga, Edo ; Schuringa, Jan Jacob</creatorcontrib><description>Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or by using the Rac inhibitor NSC23766. In long-term MS5 cocultures (leukemic) expansion, migration, adhesion, and presence of stem/progenitor cells were monitored in both normal as well as leukemic CD34+ cells. Results Inhibition of Rac signaling impaired migration and adhesion of cord blood (CB) CD34+ cells on MS5 stroma. Long-term inhibition of Rac during a 5-week coculture period on stroma prevented association of hematopoietic progenitors with the bone marrow stromal cells and resulted in a dramatic decrease in the primitive stem cell frequency (long-term culture-initiating cell) in a dose-dependent manner. Many of these phenotypes were reversed in the presence of activated Rac1-V12, including improved migration toward, and association with, MS5 cells. CD34+ AML cells were characterized by elevated levels of Rac activity (five of seven patients) and enhanced migration and adhesion to MS5 bone marrow stroma as compared to CB CD34+ cells. A dramatic decrease was observed in the formation of leukemic cobblestone area–forming cells as well as strongly diminished clonal expansion in the presence of the Rac inhibitor NSC23766. Conclusion Our data indicate that Rac signal transduction is required for the maintenance and expansion of both normal as well as leukemic stem/progenitor cells by mediating their interaction with stromal cells.</description><identifier>ISSN: 0301-472X</identifier><identifier>EISSN: 1873-2399</identifier><identifier>DOI: 10.1016/j.exphem.2007.02.006</identifier><identifier>PMID: 17577927</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Advanced Basic Science ; Aminoquinolines - pharmacology ; Antigens, CD34 - immunology ; Cell Adhesion - drug effects ; Cell Adhesion - physiology ; Cell Communication - physiology ; Cell Culture Techniques - methods ; Cell Movement - drug effects ; Cell Movement - physiology ; Cell Proliferation - drug effects ; Dose-Response Relationship, Drug ; Hematology, Oncology and Palliative Medicine ; Hematopoietic Stem Cells - cytology ; Hematopoietic Stem Cells - drug effects ; Hematopoietic Stem Cells - physiology ; Humans ; Leukemia, Myeloid - metabolism ; Neoplastic Stem Cells ; Pyrimidines - pharmacology ; rac GTP-Binding Proteins - antagonists & inhibitors ; rac GTP-Binding Proteins - physiology ; Signal Transduction - drug effects ; Signal Transduction - physiology ; Stromal Cells - cytology ; Stromal Cells - drug effects ; Stromal Cells - physiology</subject><ispartof>Experimental hematology, 2007-05, Vol.35 (5), p.782-792</ispartof><rights>International Society for Experimental Hematology</rights><rights>2007 International Society for Experimental Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c461t-e59b7362f0b2cbe23087a6abdba063db97e0f96a9bd874701dc3e2ec1139762a3</citedby><cites>FETCH-LOGICAL-c461t-e59b7362f0b2cbe23087a6abdba063db97e0f96a9bd874701dc3e2ec1139762a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.exphem.2007.02.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17577927$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rozenveld-Geugien, Marjan</creatorcontrib><creatorcontrib>Baas, Inge O</creatorcontrib><creatorcontrib>van Gosliga, Djoke</creatorcontrib><creatorcontrib>Vellenga, Edo</creatorcontrib><creatorcontrib>Schuringa, Jan Jacob</creatorcontrib><title>Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells</title><title>Experimental hematology</title><addtitle>Exp Hematol</addtitle><description>Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or by using the Rac inhibitor NSC23766. In long-term MS5 cocultures (leukemic) expansion, migration, adhesion, and presence of stem/progenitor cells were monitored in both normal as well as leukemic CD34+ cells. Results Inhibition of Rac signaling impaired migration and adhesion of cord blood (CB) CD34+ cells on MS5 stroma. Long-term inhibition of Rac during a 5-week coculture period on stroma prevented association of hematopoietic progenitors with the bone marrow stromal cells and resulted in a dramatic decrease in the primitive stem cell frequency (long-term culture-initiating cell) in a dose-dependent manner. Many of these phenotypes were reversed in the presence of activated Rac1-V12, including improved migration toward, and association with, MS5 cells. CD34+ AML cells were characterized by elevated levels of Rac activity (five of seven patients) and enhanced migration and adhesion to MS5 bone marrow stroma as compared to CB CD34+ cells. A dramatic decrease was observed in the formation of leukemic cobblestone area–forming cells as well as strongly diminished clonal expansion in the presence of the Rac inhibitor NSC23766. Conclusion Our data indicate that Rac signal transduction is required for the maintenance and expansion of both normal as well as leukemic stem/progenitor cells by mediating their interaction with stromal cells.</description><subject>Advanced Basic Science</subject><subject>Aminoquinolines - pharmacology</subject><subject>Antigens, CD34 - immunology</subject><subject>Cell Adhesion - drug effects</subject><subject>Cell Adhesion - physiology</subject><subject>Cell Communication - physiology</subject><subject>Cell Culture Techniques - methods</subject><subject>Cell Movement - drug effects</subject><subject>Cell Movement - physiology</subject><subject>Cell Proliferation - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hematopoietic Stem Cells - cytology</subject><subject>Hematopoietic Stem Cells - drug effects</subject><subject>Hematopoietic Stem Cells - physiology</subject><subject>Humans</subject><subject>Leukemia, Myeloid - metabolism</subject><subject>Neoplastic Stem Cells</subject><subject>Pyrimidines - pharmacology</subject><subject>rac GTP-Binding Proteins - antagonists & inhibitors</subject><subject>rac GTP-Binding Proteins - physiology</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><subject>Stromal Cells - cytology</subject><subject>Stromal Cells - drug effects</subject><subject>Stromal Cells - physiology</subject><issn>0301-472X</issn><issn>1873-2399</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUuLFDEQx4Mo7rj6DURy8ta9lWSm07kIsqwPWBB8gLeQTlc7me1OepP0unvyq5t2BgQvngLh_6j6FSEvGdQMWHNxqPF-3uNUcwBZA68Bmkdkw1opKi6Uekw2IIBVW8m_n5FnKR0AYLdT8JScMbmTUnG5Ib-u7mfjkwuehoH6ECczUuN7OuJyg5OzdL9MxtNSZHKYg8Nc_lLG6WKO4Qd6l0OkFscx0Yi3i4uY6Gdjqwl7ZzL21PmM0di8Vvx0eV_MMawtf0zPyZPBjAlfnN5z8u3d1dfLD9X1p_cfL99eV3bbsFzhTnVSNHyAjtsOuYBWmsZ0fWegEX2nJMKgGqO6vpVbCay3AjlaxoSSDTfinLw-5papbxdMWU8urRMYj2FJWkLDQbRtEW6PQhtDShEHPUc3mfigGegVvD7oI3i9gtfAdQFfbK9O-UtXVv9rOpEugjdHAZYt7xxGnaxDbwumiDbrPrj_NfwbYEfnnTXjDT5gOoQl-kJQM52KQX9Zj7_eHiQAY0yK3wnIrtk</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Rozenveld-Geugien, Marjan</creator><creator>Baas, Inge O</creator><creator>van Gosliga, Djoke</creator><creator>Vellenga, Edo</creator><creator>Schuringa, Jan Jacob</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070501</creationdate><title>Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells</title><author>Rozenveld-Geugien, Marjan ; Baas, Inge O ; van Gosliga, Djoke ; Vellenga, Edo ; Schuringa, Jan Jacob</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c461t-e59b7362f0b2cbe23087a6abdba063db97e0f96a9bd874701dc3e2ec1139762a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Advanced Basic Science</topic><topic>Aminoquinolines - pharmacology</topic><topic>Antigens, CD34 - immunology</topic><topic>Cell Adhesion - drug effects</topic><topic>Cell Adhesion - physiology</topic><topic>Cell Communication - physiology</topic><topic>Cell Culture Techniques - methods</topic><topic>Cell Movement - drug effects</topic><topic>Cell Movement - physiology</topic><topic>Cell Proliferation - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hematopoietic Stem Cells - cytology</topic><topic>Hematopoietic Stem Cells - drug effects</topic><topic>Hematopoietic Stem Cells - physiology</topic><topic>Humans</topic><topic>Leukemia, Myeloid - metabolism</topic><topic>Neoplastic Stem Cells</topic><topic>Pyrimidines - pharmacology</topic><topic>rac GTP-Binding Proteins - antagonists & inhibitors</topic><topic>rac GTP-Binding Proteins - physiology</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><topic>Stromal Cells - cytology</topic><topic>Stromal Cells - drug effects</topic><topic>Stromal Cells - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rozenveld-Geugien, Marjan</creatorcontrib><creatorcontrib>Baas, Inge O</creatorcontrib><creatorcontrib>van Gosliga, Djoke</creatorcontrib><creatorcontrib>Vellenga, Edo</creatorcontrib><creatorcontrib>Schuringa, Jan Jacob</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rozenveld-Geugien, Marjan</au><au>Baas, Inge O</au><au>van Gosliga, Djoke</au><au>Vellenga, Edo</au><au>Schuringa, Jan Jacob</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells</atitle><jtitle>Experimental hematology</jtitle><addtitle>Exp Hematol</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>35</volume><issue>5</issue><spage>782</spage><epage>792</epage><pages>782-792</pages><issn>0301-472X</issn><eissn>1873-2399</eissn><abstract>Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or by using the Rac inhibitor NSC23766. In long-term MS5 cocultures (leukemic) expansion, migration, adhesion, and presence of stem/progenitor cells were monitored in both normal as well as leukemic CD34+ cells. Results Inhibition of Rac signaling impaired migration and adhesion of cord blood (CB) CD34+ cells on MS5 stroma. Long-term inhibition of Rac during a 5-week coculture period on stroma prevented association of hematopoietic progenitors with the bone marrow stromal cells and resulted in a dramatic decrease in the primitive stem cell frequency (long-term culture-initiating cell) in a dose-dependent manner. Many of these phenotypes were reversed in the presence of activated Rac1-V12, including improved migration toward, and association with, MS5 cells. CD34+ AML cells were characterized by elevated levels of Rac activity (five of seven patients) and enhanced migration and adhesion to MS5 bone marrow stroma as compared to CB CD34+ cells. A dramatic decrease was observed in the formation of leukemic cobblestone area–forming cells as well as strongly diminished clonal expansion in the presence of the Rac inhibitor NSC23766. Conclusion Our data indicate that Rac signal transduction is required for the maintenance and expansion of both normal as well as leukemic stem/progenitor cells by mediating their interaction with stromal cells.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>17577927</pmid><doi>10.1016/j.exphem.2007.02.006</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-472X |
ispartof | Experimental hematology, 2007-05, Vol.35 (5), p.782-792 |
issn | 0301-472X 1873-2399 |
language | eng |
recordid | cdi_proquest_miscellaneous_70620388 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Advanced Basic Science Aminoquinolines - pharmacology Antigens, CD34 - immunology Cell Adhesion - drug effects Cell Adhesion - physiology Cell Communication - physiology Cell Culture Techniques - methods Cell Movement - drug effects Cell Movement - physiology Cell Proliferation - drug effects Dose-Response Relationship, Drug Hematology, Oncology and Palliative Medicine Hematopoietic Stem Cells - cytology Hematopoietic Stem Cells - drug effects Hematopoietic Stem Cells - physiology Humans Leukemia, Myeloid - metabolism Neoplastic Stem Cells Pyrimidines - pharmacology rac GTP-Binding Proteins - antagonists & inhibitors rac GTP-Binding Proteins - physiology Signal Transduction - drug effects Signal Transduction - physiology Stromal Cells - cytology Stromal Cells - drug effects Stromal Cells - physiology |
title | Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A10%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expansion%20of%20normal%20and%20leukemic%20human%20hematopoietic%20stem/progenitor%20cells%20requires%20Rac-mediated%20interaction%20with%20stromal%20cells&rft.jtitle=Experimental%20hematology&rft.au=Rozenveld-Geugien,%20Marjan&rft.date=2007-05-01&rft.volume=35&rft.issue=5&rft.spage=782&rft.epage=792&rft.pages=782-792&rft.issn=0301-472X&rft.eissn=1873-2399&rft_id=info:doi/10.1016/j.exphem.2007.02.006&rft_dat=%3Cproquest_cross%3E70620388%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70620388&rft_id=info:pmid/17577927&rft_els_id=S0301472X07001117&rfr_iscdi=true |